A total of 102 intersected gene targets were obtained based on 246 active ingredient-related targets and 4829 COVID-19-related disease targets, which are possible key gene targets of the bitter almond-licorice for the treatment of COVID-19 (Fig. 3), such as IL10 and IL6. This evidence concerns the gene IL6 and COVID-19.